DR. BORKELMANS
Timeline
29 events since 2012Board
Capital
Filings
Financial
Other
20122014201620182020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBmicro format · 21 days before the deadline
2025
Liquidity more than doubled current ratio 42.17 The current ratio rises from 14.72 to 42.17. Short-term debt falls from €10,093 to €4,884.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0844079548
Annual accounts 2024 filed PDFmicro format · 11 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 16 days before the deadline
2023
Liquidity more than 14 times current ratio 15.50 The current ratio rises from 1.04 to 15.50. Short-term debt falls from €193,475 to €6,925.
Annual accounts 2022 filed PDFmicro format · 23 days late
2022
Annual accounts 2021 filed PDFmicro format · 13 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 48 days late
resigns as manager reappointed as director · Director discharge: · General meeting of 10-06-20217 points ▸
- Director resignation, (manager)
- Director reappointment,
- Director discharge,
- Registered office clause, Putstraat 49
- Power of attorney,
- General meeting, 10-06-2021
- 100 shares
- The deed holds 3 more points.
2020
Annual accounts 2019 filed PDFmicro format · 76 days late
2019
Annual accounts 2018 filed PDFmicro format · 42 days late
2018
Weakest financial year net €20,417 ▼26.1% The net result drops to €20,417, the lowest from 2012 to 2025. It recovers the following year.
Liquidity more than doubled current ratio 4.32 The current ratio rises from 1.88 to 4.32. Short-term debt falls from €58,222 to €20,799.
Annual accounts 2017 filed PDFmicro format · 48 days late
Demerger: Dr. Borkelmans splits off to Dr. Groffils, praktijk ThomasboslaanFounding capital of €339,118.76 · The capital rose from €18,600 to €536,867.49 · The capital fell from €536,867.49 to €197,748.73 · appointed as manager · General meeting of 15-12-201715 points ▸
- General meeting, 15-12-2017
- Capital increase, €518,267.49
- Auditor report, 20-11-2017
- holds 50 shares
- holds 50 shares
- Accounting effect, 01-01-2017
- Capital decrease, €339,118.76
- Founding capital, €339,118.76, 100 shares
- Founder,
- Founder,
- Capital, €339,118.76, 100 shares
- 100 shares
- Director appointment, (manager (not named in the articles))
- Capital, €197,748.73, 100 shares
- Power of attorney,
- The deed holds 11 more points.
2017
Demerger proposal: Dr. Borkelmans splits off to Dr. Groffils, praktijk Thomasboslaan afgekort Dr. Groffils appointed as company auditor · Partner: (geneesheer vennoot) · Partner: · Board meeting of 01-01-20178 points ▸
- Board meeting, 01-01-2017
- Partner, (geneesheer vennoot)
- Partner,
- Capital, €18,600, 100 shares
- Registered office clause, Putstraat 49, 3630 Maasmechelen
- Share issue, €100
- Accounting effect, 01-01-2017
- Auditor appointment, (company auditor)
- The deed holds 10 more points.
Annual accounts 2016 filed PDFmicro format · 4 days late
2016
Equity above €500,000 equity €536,867 ▲31.1% With a profit in every financial year since 2012, equity grows to €536,867.
Annual accounts 2015 filed PDFabbreviated format · 78 days late
2015
Liquidity more than doubled current ratio 7.10 The current ratio rises from 2.83 to 7.10. Short-term debt falls from €98,697 to €42,018.
Annual accounts 2014 filed PDFabbreviated format · 60 days late
2014
Highest result from 2012 to 2025 net €132,632 ▲21.1% The operating result of €222,115 and the net result of €132,632 are both a record.
Equity above €200,000 equity €302,730 ▲78% With a profit in every financial year since 2012, equity grows to €302,730.
Annual accounts 2013 filed PDFabbreviated format · 122 days late
Director in office: (manager) PDF
2013
Equity above €150,000 equity €170,098 ▲181% With a profit in every financial year since 2012, equity grows to €170,098.
Annual accounts 2012 filed PDFabbreviated format · 31 days late
2012
IncorporationFounding capital of €18,600, 100 shares, €12,400 paid up · Founded by (partner and founder) · appointed as manager · published on 13-03-20123 points ▸
- Founder, (partner and founder)
- Founding capital, €18,600, 100 shares
- Director appointment, (manager)
- The deed holds 4 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank